Log in
The Opiate 2000 Drug Test Card uses a lateral flow chromatographic immunoassay to detect Morphine, a primary metabolite of opiates, in human urine. Simply dip the absorbent end of the test card into the urine specimen for the recommended time, then place it on a flat surface while the reaction develops. Results are typically available within 5 minutes.
This test provides a preliminary analytical result only. Any preliminary positive result should be confirmed using a laboratory confirmation method such as Gas Chromatography/Mass Spectrometry (GC-MS) or Liquid Chromatography–Mass Spectrometry (LC-MS/MS)
25 × Individually sealed Opiate 2000 (OPI) Drug Test Cards
Instructions for Use (IFU)
2000 ng/mL (Urine)
Opiates are a class of opioid drugs derived from the opium poppy or manufactured to produce similar effects. They are commonly prescribed to relieve moderate to severe pain but also have a high potential for misuse and dependence. This test is specifically designed to detect Morphine, one of the primary metabolites of opiates, in human urine.
The Opiate 2000 Drug Test Card uses a 2000 ng/mL cutoff concentration, making it suitable for professional urine drug screening where this screening threshold is required.
Pain relief
Relaxation
Drowsiness
Slowed breathing
Constricted pupils
Dizziness
Nausea
Reduced alertness
Smack, H, Dope, Horse, Junk, Brown Sugar.
Morphine and other opiate metabolites are typically detectable in urine for 2–3 days after use, although prolonged or heavy use may extend the detection period
The Opiate 2000 (OPI) Drug Test Card provides a fast, accurate, and convenient solution for detecting Morphine, the primary metabolite of opiates, in human urine. Featuring a 2000 ng/mL screening cutoff, simple dip-and-read operation, and results available in approximately 5 minutes, it is ideal for professional point-of-care testing as well as home use. Each test card is individually packaged for single-use convenience and delivers reliable preliminary screening results without the need for specialized equipment. As with all rapid immunoassay screening devices, any preliminary positive result should be confirmed using Gas Chromatography/Mass Spectrometry (GC-MS) or Liquid Chromatography–Mass Spectrometry (LC-MS/MS) before clinical, legal, or employment decisions are made.
The Opiate 2000 (OPI) Drug Test Card is a rapid, one-step urine drug screening test designed for the qualitative detection of Opiates (OPI) in human urine. The test specifically detects Morphine, one of the primary metabolites of opiates, at a 2,000 ng/mL cutoff concentration using a lateral flow chromatographic immunoassay.
This easy-to-use dip-and-read test delivers reliable preliminary screening results in approximately 5 minutes without requiring specialized laboratory equipment. Using highly specific monoclonal antibody technology, the test selectively detects elevated levels of morphine in urine, making it suitable for professional point-of-care and personal screening.
Each box contains 25 individually packaged test cards for convenient single-use urine drug testing
Drug
Typical Detection Window
Opiates (OPI)
2–3 Days
Drug
Cutoff Level
Opiates (Morphine)
2000 ng/mL
Two colored lines appear—one in the Control (C) region and one in the Test (T) region. Even a faint line in the Test (T) region should be interpreted as a negative result.
Only one colored line appears in the Control (C) region, while no line appears in the Test (T) region. This indicates that Morphine, the target analyte for this test, may be present at or above the 2000 ng/mL screening cutoff. Any preliminary positive result should be confirmed using Gas Chromatography/Mass Spectrometry (GC-MS) or Liquid Chromatography–Mass Spectrometry (LC-MS/MS).
If no colored line appears in the Control (C) region, the test is invalid regardless of whether a Test line appears. Repeat the test using a new test card

Opiate 2000 (OPI) Drug Test Card 2,000 ng/mL | Abbott DOP-114 25/Box
Sign up for updates from leading retailers